Literature DB >> 2498645

Effect of von Willebrand factor coexpression on the synthesis and secretion of factor VIII in Chinese hamster ovary cells.

R J Kaufman1, L C Wasley, M V Davies, R J Wise, D I Israel, A J Dorner.   

Abstract

In plasma, antihemophilic factor (factor VIII) exists as a 200-kilodalton heavy-chain polypeptide in a metal ion association with an 80-kilodalton light-chain polypeptide. This complex is bound by hydrophobic and hydrophilic interactions to a large multimeric glycoprotein, von Willebrand factor (vWF). Accumulation of secreted human factor VIII activity expressed in Chinese hamster ovary cells requires the addition of serum in the growth medium, which provides vWF. Here we report that coexpression of vWF with factor VIII in Chinese hamster ovary cells resulted in increased stable accumulation of factor VIII activity in the absence of serum in the growth medium. In the coexpressing cells, the vWF cDNA transcription unit was transcribed to yield mRNA which was efficiently translated. vWF was properly processed and secreted to yield disulfide-bonded high-molecular-weight multimers similar to those observed in vWF secreted from human endothelial cells. Nuclear run-on assays showed that the factor VIII gene was transcribed at a level similar to that of the vWF gene, but the mRNA did not accumulate to high levels in the cytoplasm. In addition, although the translation efficiency of the factor VIII mRNA was similar to that of vWF, the processing and secretion of the factor VIII primary translation product was dramatically reduced compared with vWF. These results demonstrate that in Chinese hamster ovary cells both factor VIII mRNA accumulation and the processing and secretion of the primary factor VIII translation product are inefficient processes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2498645      PMCID: PMC362714          DOI: 10.1128/mcb.9.3.1233-1242.1989

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  58 in total

1.  Reduction of endogenous GRP78 levels improves secretion of a heterologous protein in CHO cells.

Authors:  A J Dorner; M G Krane; R J Kaufman
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

2.  Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity.

Authors:  D Eaton; H Rodriguez; G A Vehar
Journal:  Biochemistry       Date:  1986-01-28       Impact factor: 3.162

3.  The nucleotide sequence encoding the hamster 78-kDa glucose-regulated protein (GRP78) and its conservation between hamster and rat.

Authors:  J Ting; S K Wooden; R Kriz; K Kelleher; R J Kaufman; A S Lee
Journal:  Gene       Date:  1987       Impact factor: 3.688

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  The role of phospholipid and factor VIIIa in the activation of bovine factor X.

Authors:  G van Dieijen; G Tans; J Rosing; H C Hemker
Journal:  J Biol Chem       Date:  1981-04-10       Impact factor: 5.157

6.  Purification of human factor VIII:C and its characterization by Western blotting using monoclonal antibodies.

Authors:  F Rotblat; D P O'Brien; F J O'Brien; A H Goodall; E G Tuddenham
Journal:  Biochemistry       Date:  1985-07-30       Impact factor: 3.162

7.  Divergent fates of von Willebrand factor and its propolypeptide (von Willebrand antigen II) after secretion from endothelial cells.

Authors:  D D Wagner; P J Fay; L A Sporn; S Sinha; S O Lawrence; V J Marder
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

8.  Purified human factor VIII procoagulant protein: comparative hemostatic response after infusions into hemophilic and von Willebrand disease dogs.

Authors:  K M Brinkhous; H Sandberg; J B Garris; C Mattsson; M Palm; T Griggs; M S Read
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

9.  Ultrastructural localization of factor VIII procoagulant antigen in human liver hepatocytes.

Authors:  M G Zelechowska; J A van Mourik; T Brodniewicz-Proba
Journal:  Nature       Date:  1985 Oct 24-30       Impact factor: 49.962

10.  The effect of thrombin on human factor VIII. Cleavage of the factor VIII procoagulant protein during activation.

Authors:  L W Hoyer; N C Trabold
Journal:  J Lab Clin Med       Date:  1981-01
View more
  35 in total

1.  Effect of transmembrane pressure on Factor VIII yield in ATF perfusion culture for the production of recombinant human Factor VIII co-expressed with von Willebrand factor.

Authors:  Seung-Chul Kim; Sora An; Hyun-Ki Kim; Beom-Soo Park; Kyu-Heum Na; Byung-Gee Kim
Journal:  Cytotechnology       Date:  2015-10-13       Impact factor: 2.058

Review 2.  Insight into the structure, function, and biosynthesis of factor VIII through recombinant DNA technology.

Authors:  R J Kaufman
Journal:  Ann Hematol       Date:  1991-09       Impact factor: 3.673

3.  Expression of human coagulation factor VIII in a human hybrid cell line, HKB11.

Authors:  Baisong Mei; Yaoqi Chen; Jianmin Chen; Clark Q Pan; John E Murphy
Journal:  Mol Biotechnol       Date:  2006-10       Impact factor: 2.695

4.  Hepatitis C and haemophilia.

Authors:  P R Foster; R V McIntosh; A J MacLeod
Journal:  BMJ       Date:  1995-09-16

Review 5.  Platelet and endothelial expression of clotting factors for the treatment of hemophilia.

Authors:  Robert R Montgomery; Qizhen Shi
Journal:  Thromb Res       Date:  2012-03-14       Impact factor: 3.944

6.  Alternative strategies for gene therapy of hemophilia.

Authors:  Robert R Montgomery; Qizhen Shi
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2010

7.  Functional factor VIII made with von Willebrand factor at high levels in transgenic milk.

Authors:  S W Pipe; H Miao; S P Butler; J Calcaterra; W H Velander
Journal:  J Thromb Haemost       Date:  2011-11       Impact factor: 5.824

8.  Endothelial cell processing and alternatively spliced transcripts of factor VIII: potential implications for coagulation cascades and pulmonary hypertension.

Authors:  Claire L Shovlin; Gillian Angus; Richard A Manning; Grace N Okoli; Fatima S Govani; Kay Elderfield; Graeme M Birdsey; Inês G Mollet; Michael A Laffan; Francesco A Mauri
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

9.  An internal ribosome binding site can be used to select for homologous recombinants at an immunoglobulin heavy-chain locus.

Authors:  C R Wood; G E Morris; E M Alderman; L Fouser; R J Kaufman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

Review 10.  Emerging trends in plasma-free manufacturing of recombinant protein therapeutics expressed in mammalian cells.

Authors:  Leopold Grillberger; Thomas R Kreil; Sonia Nasr; Manfred Reiter
Journal:  Biotechnol J       Date:  2009-02       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.